Current and emerging biomarkers of cell death in human disease

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Li, Kongning ^a   Wu, Deng ^a   Chen, Xi ^a   Zhang, Ting ^a   Zhang, Lu ^a   Yi, Ying ^a   Miao, Zhengqiang ^a   Jin, Nana ^a   Bi, Xiaoman ^a   Wang, Hongwei ^a   Xu, Jianzhen ^b   Wang, Dong ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b HENAN UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS RELATED CYSTEINE PEPTIDASE; BECLIN 1; BIOLOGICAL MARKER; CASPASE 3; CYTOKERATIN 18; FAS CELL SURFACE DEATH RECEPTOR; LONG UNTRANSLATED RNA; MICRORNA; MICROTUBULE ASSOCIATED PROTEIN 1 LIGHT CHAIN 3 ALPHA; PROTEIN; PROTEIN P53; RECEPTOR INTERACTING SERINE THREONINE KINASE 3; RECEPTOR INTERACTING SERINE-THREONINE KINASE 1; TUMOR NECROSIS FACTOR 10; UNCLASSIFIED DRUG; UNTRANSLATED RNA;

APOPTOSIS; AUTOPHAGY; CELL DEATH; HUMAN; MITOSIS; NECROSIS; REVIEW; UNIVERSITY; GENETICS;

APOPTOSIS; AUTOPHAGY; BIOLOGICAL MARKERS; HUMANS; MITOSIS; NECROSIS;

EID: 84902241543     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/690103     Document Type: Review

References (112)

1. Fuchs Y., Steller H., Programmed cell death in animal development and disease. Cell 2011 147 4 742 758 2-s2.0-81055125652 10.1016/j.cell.2011.10.033
2. Engelberg-Kulka H., Amitai S., Kolodkin-Gal I., Hazan R., Bacterial programmed cell death and multicellular behavior in bacteria. PLoS Genetics 2006 2 10 e135 2-s2.0-36248961826 10.1371/journal.pgen.0020135
3. Hengartner M. O., The biochemistry of apoptosis. Nature 2000 407 6805 770 776 2-s2.0-0034641918 10.1038/35037710
4. Kroemer G., Galluzzi L., Vandenabeele P., Abrams J., Alnemri E. S., Baehrecke E. H., Blagosklonny M. V., El-Deiry W. S., Golstein P., Green D. R., Hengartner M., Knight R. A., Kumar S., Lipton S. A., Malorni W., Nuñez G., Peter M. E., Tschopp J., Yuan J., Piacentini M., Zhivotovsky B., Melino G., Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death and Differentiation 2009 16 1 3 11 2-s2.0-57649149333 10.1038/cdd.2008.150
5. Galluzzi L., Vitale I., Abrams J. M., Alnemri E. S., Baehrecke E. H., Blagosklonny M. V., Dawson T. M., Dawson V. L., El-Deiry W. S., Fulda S., Gottlieb E., Green D. R., Hengartner M. O., Kepp O., Knight R. A., Kumar S., Lipton S. A., Lu X., Madeo F., Malorni W., Mehlen P., Nũez G., Peter M. E., Piacentini M., Rubinsztein D. C., Shi Y., Simon H.-U., Vandenabeele P., White E., Yuan J., Zhivotovsky B., Melino G., Kroemer G., Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death and Differentiation 2012 19 1 107 120 2-s2.0-84255210700 10.1038/cdd.2011.96
6. Zuzarte-Luís V., Hurlé J. M., Programmed cell death in the developing limb. International Journal of Developmental Biology 2002 46 7 871 876 2-s2.0-0036435354
7. Su M., Mei Y., Sinha S., Role of the crosstalk between autophagy and apoptosis in Cancer. Journal of Oncology 2013 2013 14 102735 10.1155/2013/102735
8. Mũoz L. E., Lauber K., Schiller M., Manfredi A. A., Herrmann M., The role of defective clearance of apoptotic cells in systemic autoimmunity. Nature Reviews Rheumatology 2010 6 5 280 289 2-s2.0-77951971046 10.1038/nrrheum.2010.46
9. Lowe S. W., Lin A. W., Apoptosis in cancer. Carcinogenesis 2000 21 3 485 495 2-s2.0-0034057320
10. Marchal J. A., Lopez G. J., Peran M., Comino A., Delgado J. R., Garcia-Garcia J. A., Conde V., Aranda F. M., Rivas C., Esteban M., The impact of PKR activation: from neurodegeneration to cancer. The FASEB Journal 2014 10.1096/fj.13-248294
11. Bonaldo P., Sandri M., Cellular and molecular mechanisms of muscle atrophy. Disease Models & Mechanisms 2013 6 25 39
12. Elmore S., Apoptosis: a review of programmed cell death. Toxicologic Pathology 2007 35 4 495 516 2-s2.0-34250308322 10.1080/01926230701320337
13. Gupta S., Agrawal A., Agrawal S., Su H., Gollapudi S., A paradox of immunodeficiency and inflammation in human aging: lessons learned from apoptosis. Immunity and Ageing 2006 3, article 5 2-s2.0-33745075615 10.1186/1742-4933-3-5
14. Neves A. A., Brindle K. M., Imaging cell death. Journal of Nuclear Medicine 2014 55 1 4
15. Nishida K., Yamaguchi O., Otsu K., Crosstalk between autophagy and apoptosis in heart disease. Circulation Research 2008 103 4 343 351 2-s2.0-50949097371 10.1161/CIRCRESAHA.108.175448
16. Marino G., Niso-Santano M., Baehrecke E. H., Kroemer G., Self-consumption: the interplay of autophagy and apoptosis. Nature Reviews Molecular Cell Biology 2014 15 81 94
17. Susin S. A., Lorenzo H. K., Zamzami N., Marzo I., Snow B. E., Brothers G. M., Mangion J., Jacotot E., Costantini P., Loeffler M., Larochette N., Goodlett D. R., Aebersold R., Siderovski D. P., Penninger J. M., Kroemer G., Molecular characterization of mitochodrial apoptosis-inducing factor. Nature 1999 397 6718 441 446 2-s2.0-0033521741 10.1038/17135
18. Igney F. H., Krammer P. H., Death and anti-death: tumour resistance to apoptosis. Nature Reviews Cancer 2002 2 4 277 288 2-s2.0-0036547417
19. Jain M. V., Paczulla A. M., Klonisch T., Dimgba F. N., Rao S. B., Roberg K., Schweizer F., Lengerke C., Davoodpour P., Palicharla V. R., Interconnections between apoptotic, autophagic and necrotic pathways: implications for cancer therapy development. Journal of Cellular and Molecular Medicine 2013 17 12 29
20. Pyo J.-O., Nah J., Jung Y.-K., Molecules and their functions in autophagy. Experimental and Molecular Medicine 2012 44 2 73 80 2-s2.0-84857802958 10.3858/emm.2012.44.2.029
21. Choi A. M., Ryter S. W., Levine B., Autophagy in human health and disease. The New England Journal of Medicine 2013 368 1845 1846
22. Wang Y., Qin Z. H., Coordination of autophagy with other cellular activities. Acta Pharmacologica Sinica 2013 34 585 594
23. Choi K. S., Autophagy and cancer. Experimental and Molecular Medicine 2012 44 2 109 120 2-s2.0-84857873299 10.3858/emm.2012.44.2.033
24. Miller S., Tavshanjian B., Oleksy A., Perisic O., Houseman B. T., Shokat K. M., Williams R. L., Shaping development of autophagy inhibitors with the structure of the lipid kinase Vps34. Science 2010 327 5973 1638 1642 2-s2.0-77950212231 10.1126/science.1184429
25. Denton D., Nicolson S., Kumar S., Cell death by autophagy: facts and apparent artefacts. Cell Death and Differentiation 2012 19 1 87 95 2-s2.0-84856748733 10.1038/cdd.2011.146
26. Vanden Berghe T., Linkermann A., Jouan-Lanhouet S., Walczak H., Vandenabeele P., Regulated necrosis: the expanding network of non-apoptotic cell death pathways. Nature Reviews Molecular Cell Biology 2014 15 135 147
27. Kim S. J., Li J., Caspase blockade induces RIP3-mediated programmed necrosis in Toll-like receptor-activated microglia. Cell Death & Disease 2013 4, article e716
28. Remijsen Q., Kuijpers T. W., Wirawan E., Lippens S., Vandenabeele P., Vanden Berghe T., Dying for a cause: NETosis, mechanisms behind an antimicrobial cell death modality. Cell Death and Differentiation 2011 18 4 581 588 2-s2.0-79952622190 10.1038/cdd.2011.1
29. Galluzzi L., Kepp O., Krautwald S., Kroemer G., Linkermann A., Molecular mechanisms of regulated necrosis. Seminars in Cell & Developmental Biology 2014 10.1016/j.semcdb.2014.02.006
30. Vitale I., Galluzzi L., Castedo M., Kroemer G., Mitotic catastrophe: a mechanism for avoiding genomic instability. Nature Reviews. Molecular Cell Biology 2011 12 6 385 392 2-s2.0-79960957085 10.1038/nrm3115
31. Imreh G., Norberg H. V., Imreh S., Zhivotovsky B., Chromosomal breaks during mitotic catastrophe trigger γ H2AX-ATM-p53-mediated apoptosis. Journal of Cell Science 2011 124 17 2951 2963 2-s2.0-80053966362 10.1242/jcs.081612
32. Vakifahmetoglu H., Olsson M., Tamm C., Heidari N., Orrenius S., Zhivotovsky B., DNA damage induces two distinct modes of cell death in ovarian carcinomas. Cell Death and Differentiation 2008 15 3 555 566 2-s2.0-39449134259 10.1038/sj.cdd.4402286
33. Castedo M., Perfettini J.-L., Roumier T., Kroemer G., Cyclin-dependent kinase-1: linking apoptosis to cell cycle and mitotic catastrophe. Cell Death and Differentiation 2002 9 12 1287 1293 2-s2.0-0036952736 10.1038/sj.cdd.4401130
34. Kimura M., Yoshioka T., Saio M., Banno Y., Nagaoka H., Okano Y., Mitotic catastrophe and cell death induced by depletion of centrosomal proteins. Cell Death & Disease 2013 4, article e603
35. Portugal J., Mansilla S., Bataller M., Mechanisms of drug-induced mitotic catastrophe in cancer cells. Current Pharmaceutical Design 2010 16 1 69 78 2-s2.0-77949450557 10.2174/138161210789941801
36. Eguchi A., Wree A., Feldstein A. E., Biomarkers of liver cell death. Journal of Hepatology 2014 60 5 1063 1074 10.1016/j.jhep.2013.12.026
37. Crea F., Clermont P. L., Parolia A., Wang Y., Helgason C. D., The non-coding transcriptome as a dynamic regulator of cancer metastasis. Cancer and Metastasis Reviews 2013 10.1007/s10555-013-9455-3
38. Guo X. X., Li Y., Sun C., Jiang D., Lin Y. J., Jin F. X., Lee S. K., Jin Y. H., p53-dependent Fas expression is critical for Ginsenoside Rh2 triggered caspase-8 activation in HeLa cells. Protein Cell 2014 5 3 224 234
39. Seirafian S., Prod'homme V., Sugrue D., Davies J., Fielding C., Tomasec P., Wilkinson G. W., Human cytomegalovirus suppresses fas expression and function. Journal of General Virology 2014 95 933 939
40. Guicciardi M. E., Gores G. J., Life and death by death receptors. The FASEB Journal 2009 23 6 1625 1637 2-s2.0-67649386107 10.1096/fj.08-111005
41. Reimers K., Radtke C., Choi C. Y., Allmeling C., Kall S., Kiefer P., Muehlberger T., Vogt P. M., Expression of TNF-related apoptosis-inducing ligand (TRAIL) in keratinocytes mediates apoptotic cell death in allogenic T cells. Annals of Surgical Innovation and Research 2009 3, article 13 2-s2.0-77955226080 10.1186/1750-1164-3-13
42. Maher S., Toomey D., Condron C., Bouchier-Hayes D., Activation-induced cell death: the controversial role of Fas and Fas ligand in immune privilege and tumour counterattack. Immunology and Cell Biology 2002 80 2 131 137 2-s2.0-0036215202 10.1046/j.1440-1711.2002.01068.x
43. Zhang Y. Q., Xiao C. X., Lin B. Y., Shi Y., Liu Y. P., Liu J. J., Guleng B., Ren J. L., Silencing of Pokemon enhances caspase-dependent apoptosis via fas- and mitochondria-mediated pathways in hepatocellular carcinoma cells. PLoS ONE 2013 8 e68981
44. Messer M. P., Kellermann P., Weber S. J., Hohmann C., Denk S., Klohs B., Schultze A., Braumuller S., Huber-Lang M. S., Perl M., Silencing of fas, fas-associated via death domain, or caspase 3 differentially affects lung inflammation, apoptosis, and development of trauma-induced septic acute lung injury. Shock 2013 39 19 27
45. Wang H.-Q., Yu X.-D., Liu Z.-H., Cheng X., Samartzis D., Jia L.-T., Wu S.-X., Huang J., Chen J., Luo Z.-J., Deregulated miR-155 promotes Fas-mediated apoptosis in human intervertebral disc degeneration by targeting FADD and caspase-3. Journal of Pathology 2011 225 2 232 242 2-s2.0-80052460614 10.1002/path.2931
46. Mao Z. G., Jiang C. C., Yang F., Rick F. Thorne R. F. T., Hersey P., Zhang X. D., TRAIL-induced apoptosis of human melanoma cells involves activation of caspase-4. Apoptosis 2010 15 10 1211 1222 2-s2.0-78650062626 10.1007/s10495-010-0513-9
47. Saqr H. E., Omran O. M., Oblinger J. L., Yates A. J., TRAIL-induced apoptosis in U-1242 MG glioma cells. Journal of Neuropathology and Experimental Neurology 2006 65 2 152 161 2-s2.0-33645029776 10.1097/01.jnen.0000199574.86170. 80
48. Hetz C. A., Hunn M., Rojas P., Torres V., Leyton L., Quest A. F. G., Caspase-dependent initiation of apoptosis and necrosis by the Fas receptor in lymphoid cells: onset of necrosis is associated with delayed ceramide increase. Journal of Cell Science 2002 115 23 4671 4863 2-s2.0-12244277466 10.1242/jcs.00153
49. Owonikoko T. K., Hossain M. S., Bhimani C., Chen Z., Kim S., Ramalingam S. S., Sun S. Y., Shin D. M., Waller E. K., Khuri F. R., Soluble FAS ligand as a biomarker of disease recurrence in differentiated thyroid cancer. Cancer 2013 119 1503 1511
50. Costagliola C., Romano V., De Tollis M., Aceto F., dell'Omo R., Romano M. R., Pedicino C., Semeraro F., TNF-alpha levels in tears: a novel biomarker to assess the degree of diabetic retinopathy. Mediators of Inflammation 2013 2013 6 629529 10.1155/2013/629529
51. McIlwain D. R., Berger T., Mak T. W., Caspase functions in cell death and disease. Cold Spring Harbor Perspectives in Biology 2013 5 a008656
52. Pop C., Salvesen G. S., Human caspases: activation, specificity, and regulation. Journal of Biological Chemistry 2009 284 33 21777 21781 2-s2.0-69249100500 10.1074/jbc.R800084200
53. Ghavami S., Hashemi M., Ande S. R., Yeganeh B., Xiao W., Eshraghi M., Bus C. J., Kadkhoda K., Wiechec E., Halayko A. J., Los M., Apoptosis and cancer: mutations within caspase genes. Journal of Medical Genetics 2009 46 8 497 510 2-s2.0-68049143304 10.1136/jmg.2009.066944
54. Sakamaki K., Satou Y., Caspases: evolutionary aspects of their functions in vertebrates. Journal of Fish Biology 2009 74 4 727 753 2-s2.0-62349098335 10.1111/j.1095-8649.2009.02184.x
55. Alcivar A., Hu S., Tang J., Yang X., DEDD and DEDD2 associate with caspase-8/10 and signal cell death. Oncogene 2003 22 2 291 297 2-s2.0-0037448684 10.1038/sj.onc.1206099
56. Huai J., Jöckel L., Schrader K., Borner C., Role of caspases and non-caspase proteases in cell death. F1000 Biology Reports 2010 2 1, article 48 2-s2.0-77955065995 10.3410/B2-48
57. Cullen S. P., Martin S. J., Caspase activation pathways: some recent progress. Cell Death and Differentiation 2009 16 7 935 938 2-s2.0-67549107386 10.1038/cdd.2009.59
58. Adrain C., Murphy B. M., Martin S. J., Molecular ordering of the caspase activation cascade initiated by the cytotoxic T lymphocyte/natural killer (CTL/NK) protease granzyme B. Journal of Biological Chemistry 2005 280 6 4663 4673 2-s2.0-14244260622 10.1074/jbc.M410915200
59. Engels I. H., Totzke G., Fischer U., Schulze-Osthoff K., Jänicke R. U., Caspase-10 sensitizes breast carcinoma cells to TRAIL-induced but not tumor necrosis factor-induced apoptosis in a caspase-3-dependent manner. Molecular and Cellular Biology 2005 25 7 2808 2818 2-s2.0-15044354180 10.1128/MCB.25.7.2808- 2818.2005
60. McDonald E. R. III, El-Deiry W. S., Suppression of caspase-8- and -10-associated RING proteins results in sensitization to death ligands and inhibition of tumor cell growth. Proceedings of the National Academy of Sciences of the United States of America 2004 101 16 6170 6175 2-s2.0-1942533472 10.1073/pnas.0307459101
61. Marsden V. S., O'Connor L., O'Reilly L. A., Silke J., Metcalf D., Ekert P. G., Huang D. C. S., Cecconi F., Kuida K., Tomaselli K. J., Roy S., Nicholson D. W., Vaux D. L., Bouillet P., Adams J. M., Strasser A., Apoptosis initiated by Bcl-2-regulated caspase activation independently of the cytochrome c/Apaf-1/caspase-9 apoptosome. Nature 2002 419 6907 634 637 2-s2.0-0037057629 10.1038/nature01101
62. Simpson K. L., Cawthorne C., Zhou C., Hodgkinson C. L., Walker M. J., Trapani F., Kadirvel M., Brown G., Dawson M. J., MacFarlane M., A caspase-3 "death-switch" in colorectal cancer cells for induced and synchronous tumor apoptosis in vitro and in vivo facilitates the development of minimally invasive cell death biomarkers. Cell Death & Disease 2013 4, article e613
63. Singh K. P., Jaffe A. S., Liang B. T., The clinical impact of circulating caspase-3 p17 level: a potential new biomarker for myocardial injury and cardiovascular disease. Future Cardiology 2011 7 4 443 445 2-s2.0-79961076739 10.2217/fca.11.29
64. Abu-Qare A. W., Abou-Donia M. B., Biomarkers of apoptosis: release of cytochrome c, activation of caspase-3, induction of 8-hydroxy-2′- deoxyguanosine, increased 3-nitrotyrosine, and alteration of p53 gene. Journal of Toxicology and Environmental Health B: Critical Reviews 2001 4 3 313 332 2-s2.0-0034927279
65. Oshima R. G., Apoptosis and keratin intermediate filaments. Cell Death and Differentiation 2002 9 5 486 492 2-s2.0-0036097410 10.1038/sj/cdd/4400988
66. John K., Wielgosz S., Schulze-Osthoff K., Bantel H., Hass R., Increased plasma levels of CK-18 as potential cell death biomarker in patients with HELLP syndrome. Cell Death & Disease 2013 4, article e886
67. Linder S., Havelka A. M., Ueno T., Shoshan M. C., Determining tumor apoptosis and necrosis in patient serum using cytokeratin 18 as a biomarker. Cancer Letters 2004 214 1 1 9 2-s2.0-4344576754 10.1016/j.canlet.2004.06.032
68. Fisher M. B., Zhang X.-Q., McConkey D. J., Benedict W. F., Measuring soluble forms of extracellular cytokeratin 18 identifies both apoptotic and necrotic mechanisms of cell death produced by adenoviral-mediated interferon α: possible use as a surrogate marker. Cancer Gene Therapy 2009 16 7 567 572 2-s2.0-67449136146 10.1038/cgt.2009.2
69. Vos M. B., Barve S., Joshi-Barve S., Carew J. D., Whitington P. F., McClain C. J., Cytokeratin 18, a marker of cell death, is increased in children with suspected nonalcoholic fatty liver disease. Journal of Pediatric Gastroenterology and Nutrition 2008 47 4 481 485 2-s2.0-59649124884
70. Amory D. W., Steffenson J. L., Forsyth R. P., Systemic and regional blood flow changes during halothane anesthesia in the Rhesus monkey. Anesthesiology 1971 35 1 81 90 2-s2.0-0015093163
71. Feldstein A. E., Alkhouri N., de Vito R., Alisi A., Lopez R., Nobili V., Serum cytokeratin-18 fragment levels are useful biomarkers for nonalcoholic steatohepatitis in children. The American Journal of Gastroenterology 2013 108 1526 1531
72. Yilmaz Y., Systematic review: caspase-cleaved fragments of cytokeratin 18-the promises and challenges of a biomarker for chronic liver disease. Alimentary Pharmacology and Therapeutics 2009 30 11-12 1103 1109 2-s2.0-70350747448 10.1111/j.1365-2036.2009.04148.x
73. Yan H. X., Wu H. P., Zhang H. L., Ashton C., Tong C., Wu J., Qian Q. J., Wang H. Y., Ying Q. L., DNA damage-induced sustained p53 activation contributes to inflammation-associated hepatocarcinogenesis in rats. Oncogene 2013 32 4565 4571
74. Roos W. P., Kaina B., DNA damage-induced cell death by apoptosis. Trends in Molecular Medicine 2006 12 9 440 450 2-s2.0-33747884339 10.1016/j.molmed. 2006.07.007
75. Iwakuma T., Lozano G., MDM2, an Introduction. Molecular Cancer Research 2003 1 14 993 1000 2-s2.0-0347716455
76. Yang Q., Liao L., Deng X., Chen R., Gray N. S., Yates J. R., Lee J. D., BMK1 is involved in the regulation of p53 through disrupting the PML-MDM2 interaction. Oncogene 2013 32 3156 3164
77. Kurki S., Latonen L., Laiho M., Cellular stress and DNA damage invoke temporally distinct Mdm2, p53 and PML complexes and damage-specific nuclear relocalization. Journal of Cell Science 2003 116 19 3917 3925 2-s2.0-0142106346 10.1242/jcs.00714
78. Yu J., Wang Z., Kinzler K. W., Vogelstein B., Zhang L., PUMA mediates the apoptotic response to p53 in colorectal cancer cells. Proceedings of the National Academy of Sciences of the United States of America 2003 100 4 1931 1936 2-s2.0-0037452759 10.1073/pnas.2627984100
79. Shen Y., White E., p53-dependent apoptosis pathways. Advances in Cancer Research 2001 82 55 84 2-s2.0-0034958237 10.1016/S0065-230X(01)82002-9
80. Barone G., Tweddle D. A., Shohet J. M., Chesler L., Moreno L., Pearson A. D., Van Maerken T., MDM2-p53 interaction in paediatric solid tumours: preclinical rationale, biomarkers and resistance. Current Drug Targets 2014 15 114 123
81. Saddler C., Ouillette P., Kujawski L., Shangary S., Talpaz M., Kaminski M., Erba H., Shedden K., Wang S., Malek S. N., Comprehensive biomarker and genomic analysis identifies p53 status as the major determinant of response to MDM2 inhibitors in chronic lymphocytic leukemia. Blood 2008 111 3 1584 1593 2-s2.0-38949135181 10.1182/blood-2007-09-112698
82. Patil V. W., Tayade M. B., Pingale S. A., Dalvi S. M., Rajekar R. B., Deshmukh H. M., Patil S. D., Singhai R., The p53 breast cancer tissue biomarker in Indian women. Breast Cancer 2011 3 71 78
83. Li L., Fukumoto M., Liu D., Prognostic significance of p53 immunoexpression in the survival of oral squamous cell carcinoma patients treated with surgery and neoadjuvant chemotherapy. Oncology Letters 2013 6 1611 1615
84. Chen K., Rajewsky N., The evolution of gene regulation by transcription factors and microRNAs. Nature Reviews Genetics 2007 8 2 93 103 2-s2.0-33846283385 10.1038/nrg1990
85. Li Y., Zhuang L., Wang Y., Hu Y., Wu Y., Wang D., Xu J., Connect the dots: a systems level approach for analyzing the miRNA-mediated cell death network. Autophagy 2013 9 436 439
86. Kren B. T., Wong P. Y.-P., Sarver A., Zhang X., Zeng Y., Steer C. J., microRNAs identified in highly purified liver-derived mitochondria may play a role in apoptosis. RNA Biology 2009 6 1 65 72 2-s2.0-62549157379
87. Xu J., Wang Y., Tan X., Jing H., MicroRNAs in autophagy and their emerging roles in crosstalk with apoptosis. Autophagy 2012 8 873 882
88. Deng G., Sui G., Noncoding RNA in oncogenesis: a new era of identifying key players. International Journal of Molecular Sciences 2013 14 18319 18349
89. Krishnan J., Mishra R. K., Emerging trends of long non-coding RNAs in gene activation. The FEBS Journal 2014 281 34 45
90. Wang Y., Chen L., Chen B., Li X., Kang J., Fan K., Hu Y., Xu J., Yi L., Yang J., Mammalian ncRNA-disease repository: a global view of ncRNA-mediated disease network. Cell Death & Disease 2013 4, article e765
91. Li Y. F., Jing Y., Hao J., Frankfort N. C., Zhou X., Shen B., Liu X., Wang L., Li R., MicroRNA-21 in the pathogenesis of acute kidney injury. Protein Cell 2013 4 813 819
92. Luo M., Shen D., Zhou X., Chen X., Wang W., MicroRNA-497 is a potential prognostic marker in human cervical cancer and functions as a tumor suppressor by targeting the insulin-like growth factor 1 receptor. Surgery 2013 153 836 847
93. Chen Y., Ke G., Han D., Liang S., Yang G., Wu X., MicroRNA-181a enhances the chemoresistance of human cervical squamous cell carcinoma to cisplatin by targeting PRKCD. Experimental Cell Research 2014 320 12 20
94. Zhao Y., Guo Q., Chen J., Hu J., Wang S., Sun Y., Role of long non-coding RNA HULC in cell proliferation, apoptosis and tumor metastasis of gastric cancer: a clinical and in vitro investigation. Oncology Reports 2014 31 358 364
95. Weber D. G., Johnen G., Casjens S., Bryk O., Pesch B., Jockel K. H., Kollmeier J., Bruning T., Evaluation of long noncoding RNA MALAT1 as a candidate blood-based biomarker for the diagnosis of non-small cell lung cancer. BMC Research Notes 2013 6, article 518
96. Porter A. G., Jänicke R. U., Emerging roles of caspase-3 in apoptosis. Cell Death and Differentiation 1999 6 2 99 104 2-s2.0-0344142396
97. Zeestraten E. C., Benard A., Reimers M. S., Schouten P. C., Liefers G. J., van de Velde C. J., Kuppen P. J., The prognostic value of the apoptosis pathway in colorectal cancer: a review of the literature on biomarkers identified by immunohistochemistry. Biomark Cancer 2013 5 13 129
98. Chakraborty J. B., Oakley F., Walsh M. J., Mechanisms and biomarkers of apoptosis in liver disease and fibrosis. International Journal of Hepatology 2012 2012 10 648915 10.1155/2012/648915
99. Ku N.-O., Toivola D. M., Strnad P., Omary M. B., Cytoskeletal keratin glycosylation protects epithelial tissue from injury. Nature Cell Biology 2010 12 9 876 885 2-s2.0-77956412905 10.1038/ncb2091
100. Kronenberger B., Von Wagner M., Herrmann E., Mihm U., Piiper A., Sarrazin C., Zeuzem S., Apoptotic cytokeratin 18 neoepitopes in serum of patients with chronic hepatitis C. Journal of Viral Hepatitis 2005 12 3 307 314 2-s2.0-18344363394 10.1111/j.1365-2893.2005.00594.x
101. Montes-Berrueta D., Ramirez L., Salmen S., Berrueta L., Fas and FasL expression in leukocytes from chronic granulomatous disease patients. Investigación Clínica 2012 53 157 167
102. Weant A. E., Michalek R. D., Khan I. U., Holbrook B. C., Willingham M. C., Grayson J. M., Apoptosis regulators Bim and Fas function concurrently to control autoimmunity and CD8+ T cell contraction. Immunity 2008 28 2 218 230 2-s2.0-38949210228 10.1016/j.immuni.2007.12.014
103. El-Karaksy S. M., Kholoussi N. M., Shahin R. M., El-Ghar M. M., Gheith Rel S., TRAIL mRNA expression in peripheral blood mononuclear cells of Egyptian SLE patients. Gene 2013 527 211 214
104. Fullgrabe J., Klionsky D. J., Joseph B., The return of the nucleus: transcriptional and epigenetic control of autophagy. Nature Reviews Molecular Cell Biology 2014 15 65 74
105. Tanida I., Ueno T., Kominami E., LC3 conjugation system in mammalian autophagy. International Journal of Biochemistry and Cell Biology 2004 36 12 2503 2518 2-s2.0-4344624322 10.1016/j.biocel.2004.05.009
106. Liang X. H., Jackson S., Seaman M., Brown K., Kempkes B., Hibshoosh H., Levine B., Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature 1999 402 6762 672 676 2-s2.0-0000906170 10.1038/45257
107. Murakami Y., Miller J. W., Vavvas D. G., RIP kinase-mediated necrosis as an alternative mechanisms of photoreceptor death. Oncotarget 2011 2 6 497 509 2-s2.0-80555133359
108. Vandenabeele P., Declercq W., Van Herreweghe F., Berghe T. V., The role of the kinases RIP1 and RIP3 in TNF-induced necrosis. Science Signaling 2010 3 115 re4 2-s2.0-77953672526 10.1126/scisignal.3115re4
109. Holler N., Zaru R., Micheau O., Thome M., Attinger A., Valitutti S., Bodmer J.-L., Schneider P., Seed B., Tschopp J., Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nature Immunology 2000 1 6 489 495 2-s2.0-5944233768
110. Lin J., Li H., Yang M., Ren J., Huang Z., Han F., Huang J., Ma J., Zhang D., Zhang Z., A role of RIP3-mediated macrophage necrosis in atherosclerosis development. Cell Reports 2013 3 200 210
111. Welz P.-S., Wullaert A., Vlantis K., Kondylis V., Fernández-Majada V., Ermolaeva M., Kirsch P., Sterner-Kock A., Van Loo G., Pasparakis M., FADD prevents RIP3-mediated epithelial cell necrosis and chronic intestinal inflammation. Nature 2011 477 7364 330 334 2-s2.0-80052850704 10.1038/nature10273
112. Zhang D.-W., Shao J., Lin J., Zhang N., Lu B.-J., Lin S.-C., Dong M.-Q., Han J., RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis. Science 2009 325 5938 332 336 2-s2.0-67650812332 10.1126/science.1172308